PMID- 32470406 OWN - NLM STAT- MEDLINE DCOM- 20210525 LR - 20210525 IS - 1873-3492 (Electronic) IS - 0009-8981 (Linking) VI - 509 DP - 2020 Oct TI - Clinical, biochemical, molecular and therapeutic characteristics of four new patients of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency. PG - 83-90 LID - S0009-8981(20)30150-9 [pii] LID - 10.1016/j.cca.2020.04.004 [doi] AB - Thirty patients with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS) deficiency, which is a rare autosomal recessive disorder caused by HMGCS2 gene mutation are known. Here, we present four new patients with this disease. The characteristics including several metabolites of patients were recorded. Next-generation targeted sequencing and multiple sequence alignment of PCR amplified products allowed for mutational analysis of HMGCS2. Minigene assay transcript analysis confirmed pathogenicity of a splice site mutation. All cases had recurrent episodes with infections while they had no symptoms during intermissions. Patient 1, a girl, showed recurrent severe metabolic acidosis after infections from 8 months old and presented with weakness, vomiting and lethargy but had normal blood glucose. After treatment, she revived completely. Patients 2, 3 and 4 were boys who showed episodes of hypoglycemia since 8, 27 and 10 months of age, respectively. Glucose infusion reversed the symptoms. All four patients had hepatomegaly and abdominal imaging showed fatty livers. Serum free fatty acid increased. Urinary dicarboxylic acids and urinary 4-hydroxy-6-methyl-2pyrone presented. Diagnosis was confirmed by HMGCS2 gene analysis and 7 mutations (p.R188H, p.F420S, p.R206C, IVS2 + 1G > T, p.E401*, p.A450Pfs*7 and p.Q427*) of this gene were found. Here we report on the characteristics and genetics of four new patients with HMGCS deficiency. This study will enrich our knowledge of this rare autosomal recessive disorder. CI - Copyright (c) 2020. Published by Elsevier B.V. FAU - Wang, Qiao AU - Wang Q AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. FAU - Yang, Yan-Ling AU - Yang YL AD - Department of Pediatrics, Peking University First Hospital, Beijing 100034, China. FAU - Liu, Min AU - Liu M AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. FAU - Chen, Jia-Jia AU - Chen JJ AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. FAU - Li, Xiao-Qiao AU - Li XQ AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. FAU - Cao, Bing-Yan AU - Cao BY AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. FAU - Gong, Chun-Xiu AU - Gong CX AD - Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Beijing 100045, China. Electronic address: chunxiugong@sina.com. LA - eng PT - Journal Article DEP - 20200526 PL - Netherlands TA - Clin Chim Acta JT - Clinica chimica acta; international journal of clinical chemistry JID - 1302422 RN - 0 (Acyl Coenzyme A) RN - 1553-55-5 (3-hydroxy-3-methylglutaryl-coenzyme A) SB - IM MH - *Acyl Coenzyme A/deficiency MH - DNA Mutational Analysis MH - Female MH - Humans MH - *Hypoglycemia MH - Infant MH - Male MH - Mutation OTO - NOTNLM OT - 3-Hydroxy-3-methylglutaryl-CoA OT - 4-Hydroxy-6-methyl-2pyrone OT - HMGCS2 OT - Hypoglycemia OT - Ketone biosynthesis COIS- Declaration of Competing Interest There are no conflicts of interest. EDAT- 2020/05/30 06:00 MHDA- 2021/05/26 06:00 CRDT- 2020/05/30 06:00 PHST- 2020/01/18 00:00 [received] PHST- 2020/04/01 00:00 [revised] PHST- 2020/04/04 00:00 [accepted] PHST- 2020/05/30 06:00 [pubmed] PHST- 2021/05/26 06:00 [medline] PHST- 2020/05/30 06:00 [entrez] AID - S0009-8981(20)30150-9 [pii] AID - 10.1016/j.cca.2020.04.004 [doi] PST - ppublish SO - Clin Chim Acta. 2020 Oct;509:83-90. doi: 10.1016/j.cca.2020.04.004. Epub 2020 May 26.